# Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer

Source: https://onco.cc/trials/nct06641635/  
OnCo record `nct06641635` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Adaptive radiotherapy in Cervical cancer, run by Peking Union Medical College Hospital, now recruiting.

## Summary

Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer is a phase 3 interventional study registered as NCT06641635 by Peking Union Medical College Hospital, with 440 participants planned, started 2024-11-19 and due to reach its primary completion in 2026-10-31. Interventions recorded: Moderated hypofractionated online adaptive radiotherapy, Conventional radiotherapy. Conditions recorded: Cervical Cancer, Adaptive Radiotherapy.

Linked to the technology Adaptive radiotherapy because the registry names it ("adaptive radiotherapy") among its interventions and Cervical cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06641635
- Phase: 3
- Setting: A Multicenter, Non-inferiority, Phase 3, Randomized Controlled Study of Moderated Hypofractionated Online Adaptive Radiotherapy for Cervical Cancer
- Sponsor: Peking Union Medical College Hospital
- Enrolled: 440

## Sources

- ClinicalTrials.gov NCT06641635: https://clinicaltrials.gov/study/NCT06641635

## Connected records

- cancers: [Cervical cancer](https://onco.cc/cancers/cervical/)
- technologies: [Adaptive radiotherapy (online replanning)](https://onco.cc/technologies/adaptive-radiotherapy/)

---
JSON: https://onco.cc/api/v1/entities/nct06641635.json